Literature DB >> 21145488

Systematic in vivo RNAi analysis identifies IAPs as NEDD8-E3 ligases.

Meike Broemer1, Tencho Tenev, Kristoffer T G Rigbolt, Sophie Hempel, Blagoy Blagoev, John Silke, Mark Ditzel, Pascal Meier.   

Abstract

The intimate relationship between mediators of the ubiquitin (Ub)-signaling system and human diseases has sparked profound interest in how Ub influences cell death and survival. While the consequence of Ub attachment is intensely studied, little is known with regards to the effects of other Ub-like proteins (UBLs), and deconjugating enzymes that remove the Ub or UBL adduct. Systematic in vivo RNAi analysis identified three NEDD8-specific isopeptidases that, when knocked down, suppress apoptosis. Consistent with the notion that attachment of NEDD8 prevents cell death, genetic ablation of deneddylase 1 (DEN1) suppresses apoptosis. Unexpectedly, we find that Drosophila and human inhibitor of apoptosis (IAP) proteins can function as E3 ligases of the NEDD8 conjugation pathway, targeting effector caspases for neddylation and inactivation. Finally, we demonstrate that DEN1 reverses this effect by removing the NEDD8 modification. Altogether, our findings indicate that IAPs not only modulate cellular processes via ubiquitylation but also through attachment of NEDD8, thereby extending the complexity of IAP-mediated signaling.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21145488     DOI: 10.1016/j.molcel.2010.11.011

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  47 in total

1.  Effect of short hairpin RNA of Bcl-xL gene on biological behaviors of HepG-2 cells.

Authors:  Duan Mengxi; Yuan Hong; Wang Nan; Li Shijun; Jiang Yanmei
Journal:  Med Oncol       Date:  2011-04-29       Impact factor: 3.064

Review 2.  The small molecule that packs a punch: ubiquitin-mediated regulation of RIPK1/FADD/caspase-8 complexes.

Authors:  Rebecca Feltham; John Silke
Journal:  Cell Death Differ       Date:  2017-06-02       Impact factor: 15.828

3.  Recognition and cleavage of related to ubiquitin 1 (Rub1) and Rub1-ubiquitin chains by components of the ubiquitin-proteasome system.

Authors:  Rajesh K Singh; Sylvia Zerath; Oded Kleifeld; Martin Scheffner; Michael H Glickman; David Fushman
Journal:  Mol Cell Proteomics       Date:  2012-10-26       Impact factor: 5.911

4.  Induction of cell senescence by targeting to Cullin-RING Ligases (CRLs) for effective cancer therapy.

Authors:  Yongfu Pan; Hua Xu; Rujiao Liu; Lijun Jia
Journal:  Int J Biochem Mol Biol       Date:  2012-09-25

5.  Regulation of parkin and PINK1 by neddylation.

Authors:  Yeun Su Choo; Georg Vogler; Danling Wang; Sreehari Kalvakuri; Anton Iliuk; W Andy Tao; Rolf Bodmer; Zhuohua Zhang
Journal:  Hum Mol Genet       Date:  2012-03-02       Impact factor: 6.150

Review 6.  Targeting Neddylation pathways to inactivate cullin-RING ligases for anticancer therapy.

Authors:  Yongchao Zhao; Meredith A Morgan; Yi Sun
Journal:  Antioxid Redox Signal       Date:  2014-02-20       Impact factor: 8.401

7.  The COP9 signalosome inhibits Cullin-RING E3 ubiquitin ligases independently of its deneddylase activity.

Authors:  Annabelle Suisse; Miklós Békés; Tony T Huang; Jessica E Treisman
Journal:  Fly (Austin)       Date:  2018-02-09       Impact factor: 2.160

8.  Nonapoptotic function of BAD and BAX in long-term depression of synaptic transmission.

Authors:  Song Jiao; Zheng Li
Journal:  Neuron       Date:  2011-05-26       Impact factor: 17.173

9.  Radiosensitization of Cancer Cells by Inactivation of Cullin-RING E3 Ubiquitin Ligases.

Authors:  Dongping Wei; Meredith A Morgan; Yi Sun
Journal:  Transl Oncol       Date:  2012-10-01       Impact factor: 4.243

10.  The deubiquitinating enzyme DUBAI stabilizes DIAP1 to suppress Drosophila apoptosis.

Authors:  C-S Yang; S A Sinenko; M J Thomenius; A C Robeson; C D Freel; S R Horn; S Kornbluth
Journal:  Cell Death Differ       Date:  2013-12-20       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.